191 related articles for article (PubMed ID: 36204809)
1. In search for a panacea for coronavirus disease-19: Analysis of ongoing clinical trials for the management of coronavirus disease-19 pandemic in India.
Maheshwari N; Roy V
Indian J Pharmacol; 2022; 54(4):258-269. PubMed ID: 36204809
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Analysis of COVID-19 Clinical Trials Registered in the Clinical Trials Registry of India.
Dutta S; Singhal S; Shah R
Cureus; 2024 Apr; 16(4):e57939. PubMed ID: 38738059
[TBL] [Abstract][Full Text] [Related]
3. A double blinded placebo controlled comparative clinical trial to evaluate the effectiveness of Siddha medicines, Kaba Sura Kudineer (KSK) & Nilavembu Kudineer (NVK) along with standard Allopathy treatment in the management of symptomatic COVID 19 patients - a structured summary of a study protocol for a randomized controlled trial.
Srivastava A; Rengaraju M; Srivastava S; Narayan V; Gupta V; Upadhayay R
Trials; 2021 Feb; 22(1):130. PubMed ID: 33573696
[TBL] [Abstract][Full Text] [Related]
4. Emerging trends from COVID-19 research registered in the Clinical Trials Registry - India.
Rao MVV; Juneja A; Maulik M; Adhikari T; Sharma S; Gupta J; Panchal Y; Yadav N
Indian J Med Res; 2021 Jan & Feb; 153(1 & 2):26-63. PubMed ID: 33818466
[TBL] [Abstract][Full Text] [Related]
5. Impact of AYUSH interventions on COVID-19: a protocol for a living systematic review and meta-analysis.
Thakar A; Panara K; Goyal M; Kumari R; Sungchol K
F1000Res; 2021; 10():674. PubMed ID: 35186267
[No Abstract] [Full Text] [Related]
6. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic clinical trials to combat COVID-19 pandemic in India: analysis from trial registry.
Batta A; Khirasaria R; Kapoor V; Varshney D
J Basic Clin Physiol Pharmacol; 2020 Dec; 32(3):267-278. PubMed ID: 33578506
[TBL] [Abstract][Full Text] [Related]
8. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS
Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282
[TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
10. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
[TBL] [Abstract][Full Text] [Related]
11. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of Ayurvedic interventions and Yoga on long term effects of COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Yadav B; Rai A; Mundada PS; Singhal R; Rao BCS; Rana R; Srikanth N
Trials; 2021 Jun; 22(1):378. PubMed ID: 34082792
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of COVID-19 Studies Registered with the Clinical Trials Registry of India [CTRI] - A database Analysis.
Vl C; Cj G; Sr B; Nn D; Nj G; Um T
J Assoc Physicians India; 2021 Oct; 69(10):11-12. PubMed ID: 34781650
[TBL] [Abstract][Full Text] [Related]
14. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
[TBL] [Abstract][Full Text] [Related]
16. Perspectives on the Early Quality of Evidence Guiding the Therapeutic Management of SARS-CoV-2: A Systematic Literature Review.
Subramanian K; Nalli A; Senthil V; Jain S; Nayak A; Bhat A
Adv Ther; 2020 Oct; 37(10):4107-4131. PubMed ID: 32809210
[TBL] [Abstract][Full Text] [Related]
17. AYUSH for COVID-19: Science or Superstition?
Priya R; Sujatha V
Indian J Public Health; 2020 Jun; 64(Supplement):S105-S107. PubMed ID: 32496237
[TBL] [Abstract][Full Text] [Related]
18. Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021).
Panovska-Stavridis I; Ridova N; Stojanoska T; Demiri I; Stevanovic M; Stojanovska S; Ristevska T; Dimkovski A; Filipce V; Dimovski A; Grozdanova A
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2021 Apr; 42(1):5-18. PubMed ID: 33894123
[TBL] [Abstract][Full Text] [Related]
19. ESCMID COVID-19 living guidelines: drug treatment and clinical management.
Bartoletti M; Azap O; Barac A; Bussini L; Ergonul O; Krause R; Paño-Pardo JR; Power NR; Sibani M; Szabo BG; Tsiodras S; Verweij PE; Zollner-Schwetz I; Rodríguez-Baño J
Clin Microbiol Infect; 2022 Feb; 28(2):222-238. PubMed ID: 34823008
[TBL] [Abstract][Full Text] [Related]
20. Ayush [Indian System of Medicines] Prophylaxis Against COVID-19: A Living Systematic Review and Meta-Analysis (Second Update).
Thakar A; Panara K; Goyal M; Kumari R; Sungchol K
J Integr Complement Med; 2024 Feb; ():. PubMed ID: 38422192
[No Abstract] [Full Text] [Related]
[Next] [New Search]
